WINDTREE THERAPEUTICS INC /DE/
WINT · Biological Products, (No Disgnostic Substances)
Latest available SEC filing: 10-Q ·
Latest disclosures
-
Latest financial period: Q3 2025
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Kucharchuk Andrew Albert: Form 3
Insider disclosure · Filed · Report period 03 Aug 2025
-
Form 3
SEC filing · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 10-K
SEC filing · Filed
-
Form 3
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
Company details and SEC sources
CIK 0000946486 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- WINT
- SEC industry group
- Biological Products, (No Disgnostic Substances) (Office of Life Sciences)
- Business address
- 2600 Kelly Road, Suite 100, Warrington, PA, 18976
- Incorporated in
- DE
- Fiscal year end
- 31 December
- Former names on EDGAR
- DISCOVERY LABORATORIES INC /DE/ (to 18 Apr 2016), ANSAN PHARMACEUTICALS INC (to 21 Jul 1997), ANSAN INC (to 15 May 1996)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields